DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call

Rhea-AI Summary

DaVita Inc. (NYSE: DVA) has announced its upcoming third quarter 2024 investor conference call, scheduled for Tuesday, October 29, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close on the same day. Investors can access the call via webcast or by dialing in, with the password "Earnings" required.

DaVita, a comprehensive kidney care provider, serves approximately 265,100 patients at 3,124 outpatient dialysis centers globally as of June 30, 2024. The company operates 2,672 centers in the United States and 452 centers across 13 other countries. DaVita focuses on transforming care delivery to improve patients' quality of life, offering services from slowing kidney disease progression to supporting transplantation and providing dialysis at home.

News Market Reaction

+3.21%

1 alert

+3.21% News Effect

On the day this news was published, DVA gained 3.21%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

DENVER, Oct. 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, October 29, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: 

Tuesday, October 29, 2024
Starting at 5:00 p.m. EDT
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.

About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers, of which 2,672 centers were located in the United States and 452 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Contact Information 
Investors:
IR@davita.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-3rd-quarter-2024-investor-conference-call-302271915.html

SOURCE DaVita

FAQ

When is DaVita's (DVA) Q3 2024 earnings call scheduled?

DaVita's Q3 2024 earnings call is scheduled for Tuesday, October 29, 2024, at 5:00 p.m. Eastern Time.

How can investors access DaVita's (DVA) Q3 2024 conference call?

Investors can access DaVita's Q3 2024 conference call via webcast on the DaVita IR web page or by dialing 877-918-6630 (US) or 517-308-9042 (International) and providing the password 'Earnings'.

How many outpatient dialysis centers does DaVita (DVA) operate as of June 30, 2024?

As of June 30, 2024, DaVita operates 3,124 outpatient dialysis centers, with 2,672 centers in the United States and 452 centers across 13 other countries.

What is the approximate number of patients DaVita (DVA) serves globally?

As of June 30, 2024, DaVita serves approximately 265,100 patients globally.

What types of kidney care services does DaVita (DVA) provide?

DaVita provides comprehensive kidney care services, including slowing kidney disease progression, supporting transplantation, acute hospital care, and dialysis at home.